Advanced breast cancer: Benefits of Trastuzumab (Herceptin) outweigh the risk of harm

In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug Trastuzumab (Herceptin) is associated with prolonged survival but also increases the risk of developing heart problems, a new systematic review shows. However, the review concludes that more women benefit from use of Trastuzumab than are harmed.
Source: ScienceDaily Headlines - Category: Science Source Type: news